全文获取类型
收费全文 | 1373篇 |
免费 | 55篇 |
国内免费 | 19篇 |
专业分类
儿科学 | 22篇 |
妇产科学 | 13篇 |
基础医学 | 164篇 |
口腔科学 | 23篇 |
临床医学 | 87篇 |
内科学 | 240篇 |
皮肤病学 | 9篇 |
神经病学 | 433篇 |
特种医学 | 58篇 |
外科学 | 52篇 |
综合类 | 37篇 |
预防医学 | 99篇 |
药学 | 119篇 |
中国医学 | 2篇 |
肿瘤学 | 89篇 |
出版年
2023年 | 5篇 |
2022年 | 5篇 |
2021年 | 9篇 |
2019年 | 8篇 |
2018年 | 8篇 |
2017年 | 14篇 |
2016年 | 13篇 |
2015年 | 17篇 |
2014年 | 27篇 |
2013年 | 73篇 |
2012年 | 45篇 |
2011年 | 46篇 |
2010年 | 35篇 |
2009年 | 39篇 |
2008年 | 53篇 |
2007年 | 58篇 |
2006年 | 51篇 |
2005年 | 48篇 |
2004年 | 47篇 |
2003年 | 56篇 |
2002年 | 67篇 |
2001年 | 58篇 |
2000年 | 63篇 |
1999年 | 65篇 |
1998年 | 42篇 |
1997年 | 30篇 |
1996年 | 29篇 |
1995年 | 26篇 |
1994年 | 19篇 |
1993年 | 23篇 |
1992年 | 39篇 |
1991年 | 33篇 |
1990年 | 29篇 |
1989年 | 28篇 |
1988年 | 35篇 |
1987年 | 29篇 |
1986年 | 15篇 |
1985年 | 19篇 |
1984年 | 15篇 |
1983年 | 13篇 |
1982年 | 14篇 |
1981年 | 8篇 |
1980年 | 10篇 |
1979年 | 13篇 |
1978年 | 10篇 |
1977年 | 6篇 |
1974年 | 6篇 |
1972年 | 6篇 |
1971年 | 5篇 |
1969年 | 5篇 |
排序方式: 共有1447条查询结果,搜索用时 0 毫秒
71.
Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis 总被引:4,自引:0,他引:4
Yu ZF Nikolova-Karakashian M Zhou D Cheng G Schuchman EH Mattson MP 《Journal of molecular neuroscience : MN》2000,15(2):85-97
Stroke is a major cause of long-term disability, the severity of which is directly related to the numbers of neurons that
succumb to the ischemic insult. The signaling cascades activated by cerebral ischemia that may either promote or protect against
neuronal death are not well-understood. One injury-responsive signaling pathway that has recently been characterized in studies
of non-neural cells involves cleavage of membrane sphingomyelin by acidic and/or neutral sphingomyelinase (ASMase) resulting
in generation of the second messenger ceramide. We now report that transient focal cerebral ischemia induces large increases
in ASMase activity, ceramide levels, and production of inflammatory cytokines in wild-type mice, but not in mice lacking ASMase.
The extent of brain tissue damage is decreased and behavioral outcome improved in mice lacking ASMase. Neurons lacking ASMase
exhibit decreased vulnerability to excitotoxicity and hypoxia, which is associated with decreased levels of intracellular
calcium and oxyradicals. Treatment of mice with a drug that inhibits ASMase activity and ceramide production reduces ischemic
neuronal injury and improves behavioral outcome, suggesting that drugs that inhibit this signaling pathway may prove beneficial
in stroke patients. 相似文献
72.
High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer. 总被引:1,自引:0,他引:1
Tarja Ruotsalainen Heikki Joensuu Karin Mattson Petri Salven 《Cancer epidemiology, biomarkers & prevention》2002,11(11):1492-1495
Basic fibroblast growth factor (bFGF) is a secreted multifunctional cytokine and a potent stimulator of angiogenesis. We measured bFGF concentrations from serum samples taken from 103 patients with small cell lung cancer at the time of diagnosis. Serum concentration of bFGF (S-bFGF) ranged from undetectable to 54 pg/ml (median, 6 pg/ml). S-bFGF was not associated with age, sex, performance status, or stage. A high pretreatment S-bFGF was associated with poor overall survival. The 1- and 2-year survival rates of the patients within the highest quartile of S-bFGF (>or=17 pg/ml) were only 26% and 11%, respectively, in contrast to the 49% and 20% 1- and 2-year survival rates of those patients with S-bFGF < 17 pg/ml (P = 0.013). The 1- and 2-year survival rates of the patients with extensive-stage disease were 33% and 10%, respectively (P = 0.0091). Interestingly, S-bFGF provided additional prognostic information to the stage because the 1- and 2-year survival rates of patients with extensive-stage disease and a high S-bFGF (>or=17 pg/ml) were as low as 16% and 5%, respectively (P = 0.0026). Similarly, in the multivariate model of survival analysis, patients with both extensive-stage disease and a high S-bFGF (>or=17 pg/ml) were found to have a particularly poor prognosis (relative risk of death, 2.1; 95% confidence interval, 1.2-3.6; P = 0.0057). We conclude that a high S-bFGF at diagnosis is associated with poor outcome in small cell lung cancer, possibly reflecting active angiogenesis and rapid tumor growth, and may complement prognostic information obtained by staging. 相似文献
73.
Evaluation of pleural disease using MR and CT. With special reference to malignant pleural mesothelioma 总被引:5,自引:0,他引:5
Knuuttila A Kivisaari L Kivisaari A Palomäki M Tervahartiala P Mattson K 《Acta radiologica (Stockholm, Sweden : 1987)》2001,42(5):502-507
Purpose: To evaluate MR imaging and CT in differentiating malignant pleural mesothelioma from other malignancies or benign pleural disease.Material and Methods: Thirty-four patients (18 pleural mesotheliomas, 9 other malignancies, 7 benign pleural diseases) were examined using enhanced CT and MR. Two radiologists reviewed the CT and two others the MR images. Comparisons were made between the diagnostic groups and the imaging methods.Results: The abnormalities commonly found in malignant disease, but significantly less frequently in benign pleural disease, were focal thickening and enhancement of interlobar fissures. In mesothelioma, enhancement of interlobar fissures, tumour invasion of the diaphragm, mediastinal soft tissue or chest wall, were significantly more often observed than in other malignancies and MR was the most sensitive method. In other malignancies, invasion of bony structures was a more common finding and was also better shown by MR. The contrast-enhanced T1 fat-suppressed (CET1fs) sequence detected these features better than other MR sequences.Conclusion: MR, especially the CET1fs sequence in three planes, gave more information than enhanced CT. Focal thickening and enhancement of interlobar fissures were early abnormalities indicating malignant pleural disease. MR could be clinically useful for differentiating mesothelioma from other pleural diseases. 相似文献
74.
Perkins SN; Hursting SD; Haines DC; James SJ; Miller BJ; Phang JM 《Carcinogenesis》1997,18(5):989-994
Transgenic mice with both alleles of the p53 tumor suppressor gene product
'knocked out' by gene targeting are susceptible to early development of
tumors, chiefly lymphomas and sarcomas. Compared with the control group,
administration of dehydroepiandrosterone (DHEA) at 0.3% of the diet to male
p53-deficient mice extended their lifespan by delaying death due to
neoplasms (from 105 to 166 days on study, P = 0.002), primarily by
suppressing lymphoblastic lymphoma (from 45 to 6% of neoplastic deaths, P =
0.010). Treatment with a synthetic DHEA analog,
16alpha-fluoro-5-androsten-17-one (compound 8354), at 0.15% of the diet
also increased lifespan, to 140 days for mice that developed tumors (P =
0.037). The effects of these steroids on lifespan and tumor development did
not appear to be strongly related to inhibition of food consumption and
weight gain, in that a group pair-fed with control diet to the reduced food
consumption of the DHEA-treated group developed and died of the same types
of neoplasms at the same rate as the controls fed ad libitum. The
chemopreventive effect of these steroids has been proposed to be due to
suppression of DNA synthesis by inhibition of glucose 6-phosphate
dehydrogenase, the rate-limiting enzyme of the pentose phosphate pathway.
Although DHEA and its analog are strong non- competitive inhibitors of this
enzyme in vitro, treatment with DHEA did not deplete cellular nucleotide
pools in the liver, as would have been predicted. The chemopreventive
effect of DHEA in this model may be due to steroid-induced thymic atrophy
and suppression of T cell lymphoma, permitting these mice to survive long
enough to develop tumors with longer latency.
相似文献
75.
AM VOGEL D LENNON SN AMERATUNGA J HOLYOAKE 《Journal of paediatrics and child health》1996,32(6):484-490
Objective : To establish the prevalence of specific chronic conditions of childhood in the Auckland area and to quantify resource use by these children.
Methodology : Estimates were made from available registry data and published data sources of the population of children with selected chronic conditions resident in the Auckland Area Health Board area. Resource use data were extracted for admissions to Auckland public hospitals and from providers of community based technology services.
Results : The largest community prevalence groups are those with asthma, intellectual handicap, congenital heart disease and epilepsy. Children aged 0-14 with chronic conditions accounted for at least 14340 hospital days stay in Auckland in 1992 at an estimated minimum cost of $7.9 million. Over 200 children are dependent on technological aids at home.
Conclusions : There are sparse data on the numbers and needs of children with chronic conditions in the population. A non-categorical approach which crosses disease entities may be the best method of meeting common needs. 相似文献
Methodology : Estimates were made from available registry data and published data sources of the population of children with selected chronic conditions resident in the Auckland Area Health Board area. Resource use data were extracted for admissions to Auckland public hospitals and from providers of community based technology services.
Results : The largest community prevalence groups are those with asthma, intellectual handicap, congenital heart disease and epilepsy. Children aged 0-14 with chronic conditions accounted for at least 14340 hospital days stay in Auckland in 1992 at an estimated minimum cost of $7.9 million. Over 200 children are dependent on technological aids at home.
Conclusions : There are sparse data on the numbers and needs of children with chronic conditions in the population. A non-categorical approach which crosses disease entities may be the best method of meeting common needs. 相似文献
76.
V Iob W J Mattson M Sloan W W Coon J G Turcotte C G Child 《Surgery, gynecology & obstetrics》1970,130(5):794-800
77.
Ollikainen T Knuuttila A Suhonen S Taavitsainen M Jekunen A Mattson K Linnainmaa K 《Anti-cancer drugs》2000,11(2):93-99
In this study, we used four human mesothelioma cell lines (M14K, M24K, M25K and M38K), one transformed human mesothelial cell line (MeT-5A) and one primary mesothelial culture (UPL) to test for in vitro sensitivity to docetaxel, paclitaxel, SN-38 [an active metabolite of irinotecan (CPT-11)] and gemcitabine, as single agents. Subconfluent cell cultures were treated with 2x10(-9), 5x10(-9), 10(-8), 2x10(-8) and 5x10(-8) M concentrations of each drug for 48 h. The sensitivity was measured in terms of cell viability using the Trypan blue exclusion method. All four drugs were potent inhibitors of mesothelioma cell growth, but cell lines from different patients diverged in their sensitivity to the individual agents. In most cases docetaxel, paclitaxel and SN-38 were more potent killers of mesothelioma cells than gemcitabine. The induction of DNA damage was investigated using the Comet assay; cells from two cell lines (M14K and M25K) were treated with subtoxic 10(-8) M concentrations of each drug for 4, 24 and 48 h. Each of the agents caused a slight increase in DNA single-strand breaks at a concentration of 10(-8) M. 相似文献
78.
Mattson K Vansteenkiste J Stupp R Bargetzi M Saarinen A Jekunen A Fillet G Teixeira M Gatzemeier U Olivares R Soussan-Lazard K Bérille J 《Anti-cancer drugs》2000,11(1):7-13
The objective of this study was to evaluate a regimen of full doses of docetaxel and cisplatin, using an alternating schedule, as first-line therapy for patients with inoperable non-small cell lung cancer (NSCLC). The standard concomitant schedule does not allow full doses of both drugs to be administered. We wanted to see if there was an advantage to be gained by administering full doses of both docetaxel and cisplatin, using a different schedule. Docetaxel 100 mg/m2 was given once every 6 weeks from week 1 and cisplatin (120 mg/m2 for two doses and 100 mg/m2 thereafter) once every 6 weeks from week 4, for six cycles (three docetaxel and three cisplatin). Thirty-six of the 44 patients enrolled were evaluable for efficacy. Forty-eight percent of the patients had good (KPS 90-100%) performance status. A median of five cycles was administered, for which no dose reductions were necessary. There were 13 of 36 partial responses (36%; 95% CI 21-54%) and 15 of 36 patients achieved stable disease (42%). The median duration of response was 10.5 months, the median time to progression was 4.5 months and the median survival was 9 months. The 1 and 2 year survival rates were 39 and 16%, respectively. The most frequent grade 3-4 toxicities were nausea (23% of patients), vomiting (18%) and neutropenia (77%). Infections were also common, but not severe. The alternating schedule produced response, toxicity and survival figures that compared favorable with those using the concomitant schedule. This study could serve as a model for future studies of non-cisplatin-containing regimens, in which full doses of docetaxel could alternate with full doses of other new agents active against NSCLC. 相似文献
79.
Jaiyesimi IA Friedline JA Mattson JC Gyorfi T Davis BH Balasubramaniam M Al-Khalili A Burdakin J Decker D Zakalik D Neumann K Wilner F 《Leukemia research》2000,24(5):417-426
The outcome of patients diagnosed myelodysplastic syndromes (MDS) between 1990 and 1997 from William Beaumont Hospital (WBH) was analyzed according to the International Prognostic Scoring System (IPSS) risk categorization. A retrospective study of 195 MDS patients wa s performed. Seventy-nine patients with MDS, in whom a karyotype was obtained and with an adequate follow-up were included in the final analysis. Cases of proliferative CMML (WBC > 12x10(9)/l) were excluded from the study. The overall median survival was 3.1 years, and median survival stratified by IPSS was 3.4, 4.1 and 0.5 years for the INT-1, INT-2 and high risk group and not yet reached for the low risk group. The overall survival by IPSS subcategorization were 6.88, 5.29, 5.30 and 2.12 years for the low, INT-1, INT-2, and high risk groups respectively. Cytogenetics were significant in predicting the overall survival. The IPSS score stratified patients into risk categories for development of AML. The risk of development into AML was 8, 8, 33 and 54% for the low, INT-1, INT-2 and high risk groups, respectively. We conclude that IPSS score can be useful in predicting survival and AML evolution in some MDS patients. 相似文献
80.
Ward A. Pedersen Weiming Fu Jeffrey N. Keller William R. Markesbery Stanley Appel R. Glenn Smith Edward Kasarskis Mark P. Mattson 《Annals of neurology》1998,44(5):819-824
We report increased modification of proteins by 4-hydroxynoneal (HNE), a product of membrane lipid peroxidation, in the lumbar spinal cord of sporadic amyotrophic lateral sclerosis (ALS) patients versus that of neurologically normal controls. By immunohistochemistry, HNE-protein modification was detected in ventral horn motor neurons, and immunoprecipitation analysis revealed that one of the proteins modified by HNE was the astrocytic glutamate transporter EAAT2. Given that the function of proteins modified by HNE can be severely compromised as previously demonstrated for glutamate transporters in cortical synaptosome preparatations, our findings suggest a scenario in which oxidative stress leads to the production of HNE, impairment of gluatmate transport, and excitotoxic motor neuron degeneration in ALS. 相似文献